I am currently undertaking a PhD within the Bristol Medical School in infectious disease modelling. Globally around 71 million people are chronically infected with the hepatitis C virus (HCV). Hepatitis C is curable but can be fatal if left untreated. It also disproportionately affects high risk groups such as people who inject drugs (PWID); in the UK approximately 85% of HCV is transmitted through injecting. PWID are also at risk of drug-related death (DRD), with overdose being the leading cause of avoidable death amongst this population. My PhD will involve developing models to determine the effect of various interventions on HCV and DRD syndemics to determine the combination that has the most positive impact. This research is motivated by the World Health Organisation’s target to eliminate HCV as a global health problem by 2030.